Skip to main content

IDEX CORP

corporate_fare Company Profile

IDEX CORP

IEX·NYSE·Industrials·CIK 0000832101

IDEX Corporation is a global provider of applied solutions, supplying critical components to specialized markets. The company operates through over 50 wholly-owned subsidiaries. IDEX focuses on solving customer technology problems and its businesses operate with significant independence, united by a philosophy of teamwork and the 8020 principle. IDEX was incorporated in Delaware on September 24, 1987. The company has three reportable segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP). These segments are structured based on customer needs, grouping businesses with similar products, end markets, distribution, and production processes. For the year ended December 31, 2025, HST contributed 43% of Net sales and 39% of Adjusted EBITDA (excluding unallocated corporate costs of $92.2 million). FMT contributed 35% of Net sales and 40% of Adjusted EBITDA. FSDP contributed 22% of Net sales and 21% of Adjusted EBITDA. For the year ended December 31, 2024, HST contributed 39% of Net sales and 36% of Adjusted EBITDA (excluding unallocated corporate costs of $93.0 million). FMT contributed 38% of Net sales and 42% of Adjusted EBITDA. FSDP contributed 23% of Net sales and 22% of Adjusted EBITDA. Beginning in 2025, the Life Sciences end market also includes analytical instruments, pharmaceutical, and medical/dental end market sales.

IDEX CORP (NYSE:IEX) is a publicly traded company in the Industrials sector. Wiseek monitors IEX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • IDEX Corporation Reports Strong Q1 2026 Results with Double-Digit EPS Growth and Robust Sales
  • IDEX Reports Strong Q1 Results, Raises Full-Year Guidance on Organic Sales & EPS Momentum
  • IDEX Files Comprehensive 10-K, Details Solid 2025 Performance and Significant Share Repurchase Program
  • IDEX Corp Eliminates Chief Strategy and Innovation Officer Role
  • IDEX Reports Record Q4 Sales & Orders, Driven by 16% Organic Order Growth in AI-Related Projects

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.46B
Net Income
$483.2M
Diluted EPS
$6.41
Op. Cash Flow
$680.4M
Free Cash Flow
$616.8M
Gross Profit
$1.54B
Operating Income
$699.3M
Cash & Equivalents
$580M
Total Debt
$1.82B
Debt / Equity
0.45×
Net Margin
14.0%
Shares Outstanding
75.3M sh
Source: 10-K · filed 2026-02-19 · accession 0000832101-26-000003
Browse all tickers starting with I →
$218.49
52-week range · as of 2026-04-29 $157.25 – $223.84
Market cap
$16.17B
Volume
477.3K (0.7× avg)
3-mo avg 649.9K
Live data · 2026-06-14 05:13 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed IEX - Latest Insights

IEX
Apr 29, 2026, 4:33 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $217.34
Real-time Price: $218.49 info
Change: +$1.15 (+0.53%) info
Market Cap: $16.172B info
IEX
Apr 29, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $215.06
Real-time Price: $218.49 info
Change: +$3.43 (+2%) info
Market Cap: $16.172B info
IEX
Feb 19, 2026, 4:33 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $207.86
Real-time Price: $218.49 info
Change: +$10.63 (+5%) info
Market Cap: $16.172B info
IEX
Feb 09, 2026, 4:36 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $210.75
Real-time Price: $218.49 info
Change: +$7.74 (+4%) info
Market Cap: $16.172B info
IEX
Feb 04, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $201.60
Real-time Price: $218.49 info
Change: +$16.89 (+8%) info
Market Cap: $16.172B info